Medical Care
Global Influenza Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- May 05, 25
- ID: 222952
- Pages: 100
- Figures: 97
- Views: 35
The global Influenza Diagnostics market size was US$ 2637 million in 2024 and is forecast to a readjusted size of US$ 4020 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).
North America is the largest consumption place, with a consumption marker share nearly 53%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
The main manufacturers are BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific etc. BD is the largest manufacturer with about 19% market share.
The global Influenza Diagnostics market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
By Type: (Dominant Segment vs High-Margin Innovation)
RIDT
RT-PCR
Cell Culture
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Hospitals
POCT
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., BD in Europe)
- Emerging Product Trends: RIDT adoption vs. RT-PCR premiumization
- Demand-Side Dynamics: Hospitals growth in China vs. POCT potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Influenza Diagnostics market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., RT-PCR in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., POCT in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Influenza Diagnostics value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).
North America is the largest consumption place, with a consumption marker share nearly 53%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
The main manufacturers are BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific etc. BD is the largest manufacturer with about 19% market share.
The global Influenza Diagnostics market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
By Type: (Dominant Segment vs High-Margin Innovation)
RIDT
RT-PCR
Cell Culture
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Hospitals
POCT
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., BD in Europe)
- Emerging Product Trends: RIDT adoption vs. RT-PCR premiumization
- Demand-Side Dynamics: Hospitals growth in China vs. POCT potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Influenza Diagnostics market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., RT-PCR in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., POCT in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Influenza Diagnostics value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 RIDT
1.2.3 RT-PCR
1.2.4 Cell Culture
1.2.5 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 POCT
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Influenza Diagnostics Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Influenza Diagnostics Revenue Market Share by Region (2020-2025)
2.4 Global Influenza Diagnostics Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Influenza Diagnostics Market Size and Prospective (2020-2031)
2.5.2 Europe Influenza Diagnostics Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Influenza Diagnostics Historic Market Size by Type (2020-2025)
3.2 Global Influenza Diagnostics Forecasted Market Size by Type (2026-2031)
3.3 Different Types Influenza Diagnostics Representative Players
4 Breakdown Data by Application
4.1 Global Influenza Diagnostics Historic Market Size by Application (2020-2025)
4.2 Global Influenza Diagnostics Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Influenza Diagnostics Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Influenza Diagnostics Players by Revenue (2020-2025)
5.1.2 Global Influenza Diagnostics Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Influenza Diagnostics Revenue
5.4 Global Influenza Diagnostics Market Concentration Analysis
5.4.1 Global Influenza Diagnostics Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Influenza Diagnostics Revenue in 2024
5.5 Global Key Players of Influenza Diagnostics Head office and Area Served
5.6 Global Key Players of Influenza Diagnostics, Product and Application
5.7 Global Key Players of Influenza Diagnostics, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Influenza Diagnostics Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Influenza Diagnostics Market Size by Type (2020-2025)
6.1.2.2 North America Influenza Diagnostics Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Influenza Diagnostics Market Size by Application (2020-2025)
6.1.3.2 North America Influenza Diagnostics Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Influenza Diagnostics Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Influenza Diagnostics Market Size by Type (2020-2025)
6.2.2.2 Europe Influenza Diagnostics Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Influenza Diagnostics Market Size by Application (2020-2025)
6.2.3.2 Europe Influenza Diagnostics Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
7 Key Players Profiles
7.1 BD
7.1.1 BD Company Details
7.1.2 BD Business Overview
7.1.3 BD Influenza Diagnostics Introduction
7.1.4 BD Revenue in Influenza Diagnostics Business (2020-2025)
7.1.5 BD Recent Development
7.2 Abbott (Include Alere)
7.2.1 Abbott (Include Alere) Company Details
7.2.2 Abbott (Include Alere) Business Overview
7.2.3 Abbott (Include Alere) Influenza Diagnostics Introduction
7.2.4 Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2020-2025)
7.2.5 Abbott (Include Alere) Recent Development
7.3 Roche
7.3.1 Roche Company Details
7.3.2 Roche Business Overview
7.3.3 Roche Influenza Diagnostics Introduction
7.3.4 Roche Revenue in Influenza Diagnostics Business (2020-2025)
7.3.5 Roche Recent Development
7.4 SIEMENS
7.4.1 SIEMENS Company Details
7.4.2 SIEMENS Business Overview
7.4.3 SIEMENS Influenza Diagnostics Introduction
7.4.4 SIEMENS Revenue in Influenza Diagnostics Business (2020-2025)
7.4.5 SIEMENS Recent Development
7.5 Analytik Jena
7.5.1 Analytik Jena Company Details
7.5.2 Analytik Jena Business Overview
7.5.3 Analytik Jena Influenza Diagnostics Introduction
7.5.4 Analytik Jena Revenue in Influenza Diagnostics Business (2020-2025)
7.5.5 Analytik Jena Recent Development
7.6 Quidel
7.6.1 Quidel Company Details
7.6.2 Quidel Business Overview
7.6.3 Quidel Influenza Diagnostics Introduction
7.6.4 Quidel Revenue in Influenza Diagnostics Business (2020-2025)
7.6.5 Quidel Recent Development
7.7 Thermo Fisher
7.7.1 Thermo Fisher Company Details
7.7.2 Thermo Fisher Business Overview
7.7.3 Thermo Fisher Influenza Diagnostics Introduction
7.7.4 Thermo Fisher Revenue in Influenza Diagnostics Business (2020-2025)
7.7.5 Thermo Fisher Recent Development
7.8 Meridian Bioscience
7.8.1 Meridian Bioscience Company Details
7.8.2 Meridian Bioscience Business Overview
7.8.3 Meridian Bioscience Influenza Diagnostics Introduction
7.8.4 Meridian Bioscience Revenue in Influenza Diagnostics Business (2020-2025)
7.8.5 Meridian Bioscience Recent Development
7.9 BioMerieux
7.9.1 BioMerieux Company Details
7.9.2 BioMerieux Business Overview
7.9.3 BioMerieux Influenza Diagnostics Introduction
7.9.4 BioMerieux Revenue in Influenza Diagnostics Business (2020-2025)
7.9.5 BioMerieux Recent Development
7.10 Sekisui Diagnostics
7.10.1 Sekisui Diagnostics Company Details
7.10.2 Sekisui Diagnostics Business Overview
7.10.3 Sekisui Diagnostics Influenza Diagnostics Introduction
7.10.4 Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2020-2025)
7.10.5 Sekisui Diagnostics Recent Development
7.11 Response Biomedical
7.11.1 Response Biomedical Company Details
7.11.2 Response Biomedical Business Overview
7.11.3 Response Biomedical Influenza Diagnostics Introduction
7.11.4 Response Biomedical Revenue in Influenza Diagnostics Business (2020-2025)
7.11.5 Response Biomedical Recent Development
7.12 SA Scientific
7.12.1 SA Scientific Company Details
7.12.2 SA Scientific Business Overview
7.12.3 SA Scientific Influenza Diagnostics Introduction
7.12.4 SA Scientific Revenue in Influenza Diagnostics Business (2020-2025)
7.12.5 SA Scientific Recent Development
8 Influenza Diagnostics Market Dynamics
8.1 Influenza Diagnostics Industry Trends
8.2 Influenza Diagnostics Market Drivers
8.3 Influenza Diagnostics Market Challenges
8.4 Influenza Diagnostics Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 RIDT
1.2.3 RT-PCR
1.2.4 Cell Culture
1.2.5 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 POCT
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Influenza Diagnostics Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Influenza Diagnostics Revenue Market Share by Region (2020-2025)
2.4 Global Influenza Diagnostics Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Influenza Diagnostics Market Size and Prospective (2020-2031)
2.5.2 Europe Influenza Diagnostics Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Influenza Diagnostics Historic Market Size by Type (2020-2025)
3.2 Global Influenza Diagnostics Forecasted Market Size by Type (2026-2031)
3.3 Different Types Influenza Diagnostics Representative Players
4 Breakdown Data by Application
4.1 Global Influenza Diagnostics Historic Market Size by Application (2020-2025)
4.2 Global Influenza Diagnostics Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Influenza Diagnostics Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Influenza Diagnostics Players by Revenue (2020-2025)
5.1.2 Global Influenza Diagnostics Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Influenza Diagnostics Revenue
5.4 Global Influenza Diagnostics Market Concentration Analysis
5.4.1 Global Influenza Diagnostics Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Influenza Diagnostics Revenue in 2024
5.5 Global Key Players of Influenza Diagnostics Head office and Area Served
5.6 Global Key Players of Influenza Diagnostics, Product and Application
5.7 Global Key Players of Influenza Diagnostics, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Influenza Diagnostics Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Influenza Diagnostics Market Size by Type (2020-2025)
6.1.2.2 North America Influenza Diagnostics Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Influenza Diagnostics Market Size by Application (2020-2025)
6.1.3.2 North America Influenza Diagnostics Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Influenza Diagnostics Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Influenza Diagnostics Market Size by Type (2020-2025)
6.2.2.2 Europe Influenza Diagnostics Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Influenza Diagnostics Market Size by Application (2020-2025)
6.2.3.2 Europe Influenza Diagnostics Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
7 Key Players Profiles
7.1 BD
7.1.1 BD Company Details
7.1.2 BD Business Overview
7.1.3 BD Influenza Diagnostics Introduction
7.1.4 BD Revenue in Influenza Diagnostics Business (2020-2025)
7.1.5 BD Recent Development
7.2 Abbott (Include Alere)
7.2.1 Abbott (Include Alere) Company Details
7.2.2 Abbott (Include Alere) Business Overview
7.2.3 Abbott (Include Alere) Influenza Diagnostics Introduction
7.2.4 Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2020-2025)
7.2.5 Abbott (Include Alere) Recent Development
7.3 Roche
7.3.1 Roche Company Details
7.3.2 Roche Business Overview
7.3.3 Roche Influenza Diagnostics Introduction
7.3.4 Roche Revenue in Influenza Diagnostics Business (2020-2025)
7.3.5 Roche Recent Development
7.4 SIEMENS
7.4.1 SIEMENS Company Details
7.4.2 SIEMENS Business Overview
7.4.3 SIEMENS Influenza Diagnostics Introduction
7.4.4 SIEMENS Revenue in Influenza Diagnostics Business (2020-2025)
7.4.5 SIEMENS Recent Development
7.5 Analytik Jena
7.5.1 Analytik Jena Company Details
7.5.2 Analytik Jena Business Overview
7.5.3 Analytik Jena Influenza Diagnostics Introduction
7.5.4 Analytik Jena Revenue in Influenza Diagnostics Business (2020-2025)
7.5.5 Analytik Jena Recent Development
7.6 Quidel
7.6.1 Quidel Company Details
7.6.2 Quidel Business Overview
7.6.3 Quidel Influenza Diagnostics Introduction
7.6.4 Quidel Revenue in Influenza Diagnostics Business (2020-2025)
7.6.5 Quidel Recent Development
7.7 Thermo Fisher
7.7.1 Thermo Fisher Company Details
7.7.2 Thermo Fisher Business Overview
7.7.3 Thermo Fisher Influenza Diagnostics Introduction
7.7.4 Thermo Fisher Revenue in Influenza Diagnostics Business (2020-2025)
7.7.5 Thermo Fisher Recent Development
7.8 Meridian Bioscience
7.8.1 Meridian Bioscience Company Details
7.8.2 Meridian Bioscience Business Overview
7.8.3 Meridian Bioscience Influenza Diagnostics Introduction
7.8.4 Meridian Bioscience Revenue in Influenza Diagnostics Business (2020-2025)
7.8.5 Meridian Bioscience Recent Development
7.9 BioMerieux
7.9.1 BioMerieux Company Details
7.9.2 BioMerieux Business Overview
7.9.3 BioMerieux Influenza Diagnostics Introduction
7.9.4 BioMerieux Revenue in Influenza Diagnostics Business (2020-2025)
7.9.5 BioMerieux Recent Development
7.10 Sekisui Diagnostics
7.10.1 Sekisui Diagnostics Company Details
7.10.2 Sekisui Diagnostics Business Overview
7.10.3 Sekisui Diagnostics Influenza Diagnostics Introduction
7.10.4 Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2020-2025)
7.10.5 Sekisui Diagnostics Recent Development
7.11 Response Biomedical
7.11.1 Response Biomedical Company Details
7.11.2 Response Biomedical Business Overview
7.11.3 Response Biomedical Influenza Diagnostics Introduction
7.11.4 Response Biomedical Revenue in Influenza Diagnostics Business (2020-2025)
7.11.5 Response Biomedical Recent Development
7.12 SA Scientific
7.12.1 SA Scientific Company Details
7.12.2 SA Scientific Business Overview
7.12.3 SA Scientific Influenza Diagnostics Introduction
7.12.4 SA Scientific Revenue in Influenza Diagnostics Business (2020-2025)
7.12.5 SA Scientific Recent Development
8 Influenza Diagnostics Market Dynamics
8.1 Influenza Diagnostics Industry Trends
8.2 Influenza Diagnostics Market Drivers
8.3 Influenza Diagnostics Market Challenges
8.4 Influenza Diagnostics Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Influenza Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Influenza Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Influenza Diagnostics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Influenza Diagnostics Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Influenza Diagnostics Revenue Share by Region (2020-2025)
Table 6. Global Influenza Diagnostics Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Influenza Diagnostics Revenue Share Forecast by Region (2026-2031)
Table 8. Global Influenza Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Influenza Diagnostics Revenue Market Share by Type (2020-2025)
Table 10. Global Influenza Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Influenza Diagnostics Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Influenza Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Influenza Diagnostics Revenue Market Share by Application (2020-2025)
Table 15. Global Influenza Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Influenza Diagnostics Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Influenza Diagnostics Application
Table 18. Global Influenza Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Influenza Diagnostics Market Share by Players (2020-2025)
Table 20. Global Top Influenza Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Diagnostics as of 2024)
Table 21. Ranking of Global Top Influenza Diagnostics Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Influenza Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Influenza Diagnostics, Headquarters and Area Served
Table 24. Global Key Players of Influenza Diagnostics, Product and Application
Table 25. Global Key Players of Influenza Diagnostics, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Influenza Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Influenza Diagnostics Revenue Market Share by Company (2020-2025)
Table 29. North America Influenza Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Influenza Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Influenza Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Influenza Diagnostics Revenue Market Share by Company (2020-2025)
Table 33. Europe Influenza Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Influenza Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 35. BD Company Details
Table 36. BD Business Overview
Table 37. BD Influenza Diagnostics Product
Table 38. BD Revenue in Influenza Diagnostics Business (2020-2025) & (US$ Million)
Table 39. BD Recent Development
Table 40. Abbott (Include Alere) Company Details
Table 41. Abbott (Include Alere) Business Overview
Table 42. Abbott (Include Alere) Influenza Diagnostics Product
Table 43. Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2020-2025) & (US$ Million)
Table 44. Abbott (Include Alere) Recent Development
Table 45. Roche Company Details
Table 46. Roche Business Overview
Table 47. Roche Influenza Diagnostics Product
Table 48. Roche Revenue in Influenza Diagnostics Business (2020-2025) & (US$ Million)
Table 49. Roche Recent Development
Table 50. SIEMENS Company Details
Table 51. SIEMENS Business Overview
Table 52. SIEMENS Influenza Diagnostics Product
Table 53. SIEMENS Revenue in Influenza Diagnostics Business (2020-2025) & (US$ Million)
Table 54. SIEMENS Recent Development
Table 55. Analytik Jena Company Details
Table 56. Analytik Jena Business Overview
Table 57. Analytik Jena Influenza Diagnostics Product
Table 58. Analytik Jena Revenue in Influenza Diagnostics Business (2020-2025) & (US$ Million)
Table 59. Analytik Jena Recent Development
Table 60. Quidel Company Details
Table 61. Quidel Business Overview
Table 62. Quidel Influenza Diagnostics Product
Table 63. Quidel Revenue in Influenza Diagnostics Business (2020-2025) & (US$ Million)
Table 64. Quidel Recent Development
Table 65. Thermo Fisher Company Details
Table 66. Thermo Fisher Business Overview
Table 67. Thermo Fisher Influenza Diagnostics Product
Table 68. Thermo Fisher Revenue in Influenza Diagnostics Business (2020-2025) & (US$ Million)
Table 69. Thermo Fisher Recent Development
Table 70. Meridian Bioscience Company Details
Table 71. Meridian Bioscience Business Overview
Table 72. Meridian Bioscience Influenza Diagnostics Product
Table 73. Meridian Bioscience Revenue in Influenza Diagnostics Business (2020-2025) & (US$ Million)
Table 74. Meridian Bioscience Recent Development
Table 75. BioMerieux Company Details
Table 76. BioMerieux Business Overview
Table 77. BioMerieux Influenza Diagnostics Product
Table 78. BioMerieux Revenue in Influenza Diagnostics Business (2020-2025) & (US$ Million)
Table 79. BioMerieux Recent Development
Table 80. Sekisui Diagnostics Company Details
Table 81. Sekisui Diagnostics Business Overview
Table 82. Sekisui Diagnostics Influenza Diagnostics Product
Table 83. Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2020-2025) & (US$ Million)
Table 84. Sekisui Diagnostics Recent Development
Table 85. Response Biomedical Company Details
Table 86. Response Biomedical Business Overview
Table 87. Response Biomedical Influenza Diagnostics Product
Table 88. Response Biomedical Revenue in Influenza Diagnostics Business (2020-2025) & (US$ Million)
Table 89. Response Biomedical Recent Development
Table 90. SA Scientific Company Details
Table 91. SA Scientific Business Overview
Table 92. SA Scientific Influenza Diagnostics Product
Table 93. SA Scientific Revenue in Influenza Diagnostics Business (2020-2025) & (US$ Million)
Table 94. SA Scientific Recent Development
Table 95. Influenza Diagnostics Market Trends
Table 96. Influenza Diagnostics Market Drivers
Table 97. Influenza Diagnostics Market Challenges
Table 98. Influenza Diagnostics Market Restraints
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Diagnostics Product Picture
Figure 2. Global Influenza Diagnostics Market Share by Type: 2024 VS 2031
Figure 3. RIDT Features
Figure 4. RT-PCR Features
Figure 5. Cell Culture Features
Figure 6. Others Features
Figure 7. Global Influenza Diagnostics Market Share by Application: 2024 VS 2031
Figure 8. Hospitals
Figure 9. POCT
Figure 10. Others
Figure 11. Influenza Diagnostics Report Years Considered
Figure 12. Global Influenza Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Influenza Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Influenza Diagnostics Revenue Market Share by Region: 2020 VS 2024
Figure 15. North America Influenza Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Europe Influenza Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Global Influenza Diagnostics Market Share by Players in 2024
Figure 18. Global Top Influenza Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Diagnostics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Influenza Diagnostics Revenue in 2024
Figure 20. North America Influenza Diagnostics Market Share by Type (2020-2025)
Figure 21. North America Influenza Diagnostics Market Share by Application (2020-2025)
Figure 22. Europe Influenza Diagnostics Market Share by Type (2020-2025)
Figure 23. Europe Influenza Diagnostics Market Share by Application (2020-2025)
Figure 24. BD Revenue Growth Rate in Influenza Diagnostics Business (2020-2025)
Figure 25. Abbott (Include Alere) Revenue Growth Rate in Influenza Diagnostics Business (2020-2025)
Figure 26. Roche Revenue Growth Rate in Influenza Diagnostics Business (2020-2025)
Figure 27. SIEMENS Revenue Growth Rate in Influenza Diagnostics Business (2020-2025)
Figure 28. Analytik Jena Revenue Growth Rate in Influenza Diagnostics Business (2020-2025)
Figure 29. Quidel Revenue Growth Rate in Influenza Diagnostics Business (2020-2025)
Figure 30. Thermo Fisher Revenue Growth Rate in Influenza Diagnostics Business (2020-2025)
Figure 31. Meridian Bioscience Revenue Growth Rate in Influenza Diagnostics Business (2020-2025)
Figure 32. BioMerieux Revenue Growth Rate in Influenza Diagnostics Business (2020-2025)
Figure 33. Sekisui Diagnostics Revenue Growth Rate in Influenza Diagnostics Business (2020-2025)
Figure 34. Response Biomedical Revenue Growth Rate in Influenza Diagnostics Business (2020-2025)
Figure 35. SA Scientific Revenue Growth Rate in Influenza Diagnostics Business (2020-2025)
Figure 36. Bottom-up and Top-down Approaches for This Report
Figure 37. Data Triangulation
Figure 38. Key Executives Interviewed
Table 1. Global Influenza Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Influenza Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Influenza Diagnostics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Influenza Diagnostics Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Influenza Diagnostics Revenue Share by Region (2020-2025)
Table 6. Global Influenza Diagnostics Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Influenza Diagnostics Revenue Share Forecast by Region (2026-2031)
Table 8. Global Influenza Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Influenza Diagnostics Revenue Market Share by Type (2020-2025)
Table 10. Global Influenza Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Influenza Diagnostics Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Influenza Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Influenza Diagnostics Revenue Market Share by Application (2020-2025)
Table 15. Global Influenza Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Influenza Diagnostics Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Influenza Diagnostics Application
Table 18. Global Influenza Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Influenza Diagnostics Market Share by Players (2020-2025)
Table 20. Global Top Influenza Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Diagnostics as of 2024)
Table 21. Ranking of Global Top Influenza Diagnostics Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Influenza Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Influenza Diagnostics, Headquarters and Area Served
Table 24. Global Key Players of Influenza Diagnostics, Product and Application
Table 25. Global Key Players of Influenza Diagnostics, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Influenza Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Influenza Diagnostics Revenue Market Share by Company (2020-2025)
Table 29. North America Influenza Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Influenza Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Influenza Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Influenza Diagnostics Revenue Market Share by Company (2020-2025)
Table 33. Europe Influenza Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Influenza Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 35. BD Company Details
Table 36. BD Business Overview
Table 37. BD Influenza Diagnostics Product
Table 38. BD Revenue in Influenza Diagnostics Business (2020-2025) & (US$ Million)
Table 39. BD Recent Development
Table 40. Abbott (Include Alere) Company Details
Table 41. Abbott (Include Alere) Business Overview
Table 42. Abbott (Include Alere) Influenza Diagnostics Product
Table 43. Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2020-2025) & (US$ Million)
Table 44. Abbott (Include Alere) Recent Development
Table 45. Roche Company Details
Table 46. Roche Business Overview
Table 47. Roche Influenza Diagnostics Product
Table 48. Roche Revenue in Influenza Diagnostics Business (2020-2025) & (US$ Million)
Table 49. Roche Recent Development
Table 50. SIEMENS Company Details
Table 51. SIEMENS Business Overview
Table 52. SIEMENS Influenza Diagnostics Product
Table 53. SIEMENS Revenue in Influenza Diagnostics Business (2020-2025) & (US$ Million)
Table 54. SIEMENS Recent Development
Table 55. Analytik Jena Company Details
Table 56. Analytik Jena Business Overview
Table 57. Analytik Jena Influenza Diagnostics Product
Table 58. Analytik Jena Revenue in Influenza Diagnostics Business (2020-2025) & (US$ Million)
Table 59. Analytik Jena Recent Development
Table 60. Quidel Company Details
Table 61. Quidel Business Overview
Table 62. Quidel Influenza Diagnostics Product
Table 63. Quidel Revenue in Influenza Diagnostics Business (2020-2025) & (US$ Million)
Table 64. Quidel Recent Development
Table 65. Thermo Fisher Company Details
Table 66. Thermo Fisher Business Overview
Table 67. Thermo Fisher Influenza Diagnostics Product
Table 68. Thermo Fisher Revenue in Influenza Diagnostics Business (2020-2025) & (US$ Million)
Table 69. Thermo Fisher Recent Development
Table 70. Meridian Bioscience Company Details
Table 71. Meridian Bioscience Business Overview
Table 72. Meridian Bioscience Influenza Diagnostics Product
Table 73. Meridian Bioscience Revenue in Influenza Diagnostics Business (2020-2025) & (US$ Million)
Table 74. Meridian Bioscience Recent Development
Table 75. BioMerieux Company Details
Table 76. BioMerieux Business Overview
Table 77. BioMerieux Influenza Diagnostics Product
Table 78. BioMerieux Revenue in Influenza Diagnostics Business (2020-2025) & (US$ Million)
Table 79. BioMerieux Recent Development
Table 80. Sekisui Diagnostics Company Details
Table 81. Sekisui Diagnostics Business Overview
Table 82. Sekisui Diagnostics Influenza Diagnostics Product
Table 83. Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2020-2025) & (US$ Million)
Table 84. Sekisui Diagnostics Recent Development
Table 85. Response Biomedical Company Details
Table 86. Response Biomedical Business Overview
Table 87. Response Biomedical Influenza Diagnostics Product
Table 88. Response Biomedical Revenue in Influenza Diagnostics Business (2020-2025) & (US$ Million)
Table 89. Response Biomedical Recent Development
Table 90. SA Scientific Company Details
Table 91. SA Scientific Business Overview
Table 92. SA Scientific Influenza Diagnostics Product
Table 93. SA Scientific Revenue in Influenza Diagnostics Business (2020-2025) & (US$ Million)
Table 94. SA Scientific Recent Development
Table 95. Influenza Diagnostics Market Trends
Table 96. Influenza Diagnostics Market Drivers
Table 97. Influenza Diagnostics Market Challenges
Table 98. Influenza Diagnostics Market Restraints
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Diagnostics Product Picture
Figure 2. Global Influenza Diagnostics Market Share by Type: 2024 VS 2031
Figure 3. RIDT Features
Figure 4. RT-PCR Features
Figure 5. Cell Culture Features
Figure 6. Others Features
Figure 7. Global Influenza Diagnostics Market Share by Application: 2024 VS 2031
Figure 8. Hospitals
Figure 9. POCT
Figure 10. Others
Figure 11. Influenza Diagnostics Report Years Considered
Figure 12. Global Influenza Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Influenza Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Influenza Diagnostics Revenue Market Share by Region: 2020 VS 2024
Figure 15. North America Influenza Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Europe Influenza Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Global Influenza Diagnostics Market Share by Players in 2024
Figure 18. Global Top Influenza Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Diagnostics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Influenza Diagnostics Revenue in 2024
Figure 20. North America Influenza Diagnostics Market Share by Type (2020-2025)
Figure 21. North America Influenza Diagnostics Market Share by Application (2020-2025)
Figure 22. Europe Influenza Diagnostics Market Share by Type (2020-2025)
Figure 23. Europe Influenza Diagnostics Market Share by Application (2020-2025)
Figure 24. BD Revenue Growth Rate in Influenza Diagnostics Business (2020-2025)
Figure 25. Abbott (Include Alere) Revenue Growth Rate in Influenza Diagnostics Business (2020-2025)
Figure 26. Roche Revenue Growth Rate in Influenza Diagnostics Business (2020-2025)
Figure 27. SIEMENS Revenue Growth Rate in Influenza Diagnostics Business (2020-2025)
Figure 28. Analytik Jena Revenue Growth Rate in Influenza Diagnostics Business (2020-2025)
Figure 29. Quidel Revenue Growth Rate in Influenza Diagnostics Business (2020-2025)
Figure 30. Thermo Fisher Revenue Growth Rate in Influenza Diagnostics Business (2020-2025)
Figure 31. Meridian Bioscience Revenue Growth Rate in Influenza Diagnostics Business (2020-2025)
Figure 32. BioMerieux Revenue Growth Rate in Influenza Diagnostics Business (2020-2025)
Figure 33. Sekisui Diagnostics Revenue Growth Rate in Influenza Diagnostics Business (2020-2025)
Figure 34. Response Biomedical Revenue Growth Rate in Influenza Diagnostics Business (2020-2025)
Figure 35. SA Scientific Revenue Growth Rate in Influenza Diagnostics Business (2020-2025)
Figure 36. Bottom-up and Top-down Approaches for This Report
Figure 37. Data Triangulation
Figure 38. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232